Dr. Seigo Izumo is Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs Japan at Takeda Pharmaceutical Company. He is responsible for Takeda’s strategic initiative in regenerative medicine business.
Previously he served as Senior VP and Head of Cardiovascular Therapeutics at Gilead Sciences, and VP and Global Head of Cardiovascular Research at Novartis Institute of Biomedical Research. Prior to joining the industry, Dr. Izumo was Professor of Medicine, Harvard Medical School and Director of Cardiovascular Research, Beth Israel Deaconess Medical Center, Boston.
Dr. Izumo graduated from University of Tokyo and received clinical and research trainings at Harvard-affiliated Beth Israel Hospital and The Children’s Hospital, Boston. He is a board-certified physician in internal medicine and cardiovascular disease.